賽瑞恩腫瘤藥劑

1.21

+0.02001.68%

成交量：71.52萬

成交額：86.54萬

市值：- -

市盈率：- -

高：1.22

開：1.19

低：1.17

收：1.19

52周最高：4.11

52周最低：0.9000

股本：- -

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

賽瑞恩腫瘤藥劑

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.oncothyreon.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Biomera is engaged primarily in the research and development of innovative therapeutic approaches for cancer management.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/ONTY/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"ONTY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONTY\",,,,,undefined,":{"symbol":"ONTY","market":"US","secType":"STK","nameCN":"賽瑞恩腫瘤藥劑","latestPrice":1.21,"timestamp":1465416000000,"preClose":1.19,"halted":0,"volume":715197,"delay":0,"changeRate":0.016806722689075647,"floatShares":0,"shares":0,"eps":0,"marketStatus":"盤前交易","change":0.02,"latestTime":"02-26 08:29:28 EST","open":1.19,"high":1.22,"low":1.1699,"amount":865388.37,"amplitude":0.042101,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1772116200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":1.21,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONTY\",,,,,undefined,":{"symbol":"ONTY","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":1.22,"amplitude":0.042101,"preClose":1.19,"low":1.1699,"week52Low":0.9,"pbRate":"--","week52High":4.11,"institutionHeld":0.8562,"latestPrice":1.21,"eps":0,"divideRate":0,"volume":715197,"delay":0,"open":1.19},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONTY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2016-05-09","symbol":"ONTY","expectedEps":-0.14,"name":"赛瑞恩肿瘤药剂","time":"","type":"earning","dateTimestamp":1462766400000,"reportTimeType":""},{"market":"US","date":"2016-03-14","symbol":"ONTY","expectedEps":-0.09,"name":"赛瑞恩肿瘤药剂","time":"","type":"earning","dateTimestamp":1457928000000,"reportTimeType":"","actualEps":-0.1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONTY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONTY\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.oncothyreon.com","compareEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0198},{"period":"6month","weight":0.0746},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.0165}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Biomera is engaged primarily in the research and development of innovative therapeutic approaches for cancer management.","exchange":"NASDAQ","name":"賽瑞恩腫瘤藥劑","nameEN":"Oncothyreon Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ONTY\",market:\"US\",,,undefined,":null}}